Search results for "vasculopathy"

showing 5 items of 5 documents

Polypoidal choroidal vasculopathy in pachychoroid: combined treatment with photodynamic therapy and aflibercept

2022

Abstract Introduction To evaluate the effects of combined therapy using intravitreal Aflibercept (IVA) and photodynamic therapy (PDT) on polypoidal choroidal vasculopathy related to pachychoroid disease (PPCV).Methods Patients with PPCV were treated with PDT combined with 3 IVA injections on a monthly basis, followed by pro re nata criteria. The 12-month follow-up consisted of multiple revaluations of visual acuity and SSOCT parameters of clinical activity.Results Nineteen eyes were included in the study; mean age was 65.5 years. Visual acuity improved after 12 months (0.35 ± 0.25 to 0.2 ± 0.20 logMAR, p = 0.005). Percentage of eyes with intraretinal and subretinal fluid reduced from baseli…

Oncologymedicine.medical_specialtygenetic structuresRecombinant Fusion Proteinsmedicine.medical_treatmentAngiogenesis InhibitorsPhotodynamic therapyPhotodynamic therapyCombined treatmentInternal medicinePolypoidal choroidal vasculopathyHumansMedicinePachychoroidFluorescein AngiographyAgedRetrospective StudiesAfliberceptbusiness.industryeye diseasesOphthalmologyReceptors Vascular Endothelial Growth FactorTreatment OutcomePhotochemotherapyIntravitreal InjectionsbusinessAfliberceptSwept Source OCTTomography Optical Coherencemedicine.drugInternational Ophthalmology
researchProduct

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry

2021

Heart retransplantation (ReHT) is controversial in the current era. The aim of this study was to describe and analyze the results of ReHT in Spain. Methods We performed a retrospective cohort analysis from the Spanish Heart Transplant Registry from 1984 to 2018. Data were collected on donors, recipients, surgical procedure characteristics, immunosuppression, and survival. The main outcome was posttransplant all-cause mortality or need for ReHT. We studied differences in survival according to indication for ReHT, the time interval between transplants and era of ReHT. Results A total of 7592 heart transplants (HT) and 173 (2.3%) ReHT were studied (median age, 52.0 and 55.0 years, respectively…

Graft RejectionReoperationmedicine.medical_specialtyTrasplante cardiacoSurvivalmedicine.medical_treatmentRetrasplante cardiacoEnfermedad cardiovascularCardiac allograft vasculopathyCold Ischemia TimeHeart retransplantation Heart transplant Retrasplante cardiaco Supervivencia Survival Trasplante cardiacoCirugíaInternal medicinemedicineHumansRegistriesTrasplante de corazónBalloon pumpPrimary graft failureRetrospective StudiesMechanical ventilationHeart transplantsSupervivenciabusiness.industryAnálisis de datosImmunosuppressionRetrospective cohort studyGeneral MedicineMiddle AgedSpainHeart retransplantationCardiologyHeart TransplantationHeart transplantbusiness
researchProduct

Non-HLA Antibodies in Hand Transplant Recipients Are Connected to Multiple Acute Rejection Episodes and Endothelial Activation

2022

The role of anti-HLA antibodies in transplant rejection is well-known but the injury associated with non-HLA antibodies is now widely discussed. The aim of our study was to investigate a role of non-HLA antibodies in hand allografts rejection. The study was performed on six patients after hand transplantation. The control group consisted of: 12 kidney transplant recipients and 12 healthy volunteers. The following non-HLA antibodies were tested: antibody against angiotensin II type 1 receptor (AT1R-Ab), antibody against endothelin-1 type-A-receptor (ETAR-Ab), antibody against protease-activated receptor 1 (PAR-1-Ab) and anti-VEGF-A antibody (VEGF-A-Ab). Chosen proinflammatory cytokines (Il-1…

vascularized composite allotransplantationhand transplantation; non-HLA antibodies; rejection; vasculopathy; vascularized composite allotransplantationRMedicineGeneral Medicinerejectionvasculopathynon-HLA antibodieshand transplantationJournal of Clinical Medicine
researchProduct

Dermatopatología de la oclusión intraluminal vascular: parte II (coagulopatías, émbolos y miscelánea)

2021

Resumen: La patología vascular oclusiva es causante de diversas y variadas manifestaciones clínicas, algunas de ellas con catastróficas consecuencias para el paciente. Dado que las causas de tal oclusión son muy variadas, hemos abordado en un artículo previo reciente en esta misma revista las causas trombóticas. En el presente artículo recopilamos diversas causas adicionales de oclusión intravascular. Abstract: Vascular occlusion has multiple, diverse clinical manifestations, some of which can have grave consequences for patients. It also has a wide variety of causes, including thrombi, which we recently addressed in part I of this review. In this second part, we look at additional causes o…

Pathologymedicine.medical_specialtybusiness.industryCalciphylaxisGeneral MedicineDermatologyDisseminated intravascular coagulationVascular occlusionRC31-1245030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineLivedoid vasculopathy030220 oncology & carcinogenesisRL1-803medicineBlood coagulation disordersmedicine.symptombusinessDegos diseaseInternal medicineCoagulation DisorderActas Dermo-Sifiliográficas
researchProduct

Semi-automated evaluation tool for retinal vasculopathy.

2009

The ocular fundus is the only area of human body where vascular system is visible using relatively simple instrumentation. Furthermore, there is medical suggestive evidence of a direct relationship between certain measures of vascular characteristics in the ocular fundus (arteriolar and venular calibers and focal arteriolar narrowing) and cardiovascular diseases. In order to establish such relationship on sound statistical basis a method must be provided to measure the needed values in an easy, yet precise and repeatable way. This paper presents a system to assist physicians in signaling and storing the data associated to signs of vascular deterioration and vascular calibers in non-mydriati…

Computer scienceHealth InformaticsFundus (eye)Sensitivity and SpecificityPattern Recognition AutomatedUser-Computer InterfaceRetinal DiseasesArtificial IntelligenceImage Interpretation Computer-AssistedmedicinePhotographyHumansComputer visionInstrumentation (computer programming)Vascular DiseasesRetinoscopymedicine.diagnostic_testbusiness.industryPhotographyReproducibility of ResultsRetinal Vesselseye diseasesComputer Science ApplicationsRetinal vasculopathyArtificial intelligencebusinessAlgorithmsSoftwareRetinoscopyComputer methods and programs in biomedicine
researchProduct